BBC
Virtus LifeSci Biotech Clinical
BBC
28,57
0,01 Bil. AUM
0,8% Expense Ratio
31,08 NAV
Virtus LifeSci Biotech Clinical Profile
About Virtus LifeSci Biotech Clinical
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
- Company
- Holdings
- 195
- CUSIP
- 26923G301
Virtus LifeSci Biotech Clinical Sectors
| Industry | Percentage |
|---|---|
| Other | 76,48% |
| Financial Servic | 6,84% |
| Real Estate | 6,02% |
| Utilities | 4,14% |
| Industrials | 3,63% |
| Communication Se | 1,94% |
| Technology | 0,88% |
| Healthcare | 0,06% |